Praxis Precision Medicines (PRAX) Net Margin (2023 - 2024)
Praxis Precision Medicines (PRAX) recorded quarterly Net Margin of 856.97% in Q4 2024, up 95.45% quarter-over-quarter from 18819.54% in Q3 2024, and up 454225.0% on a YoY basis from N/an in Q1 2024.
Praxis Precision Medicines (PRAX) Net Margin (2023 - 2024) Analysis & Trends
Praxis Precision Medicines' Net Margin history runs 2 years deep, the most recent figure standing at 856.97% for Q4 2024.
- In Q4 2024, Net Margin rose 454225.0% year-over-year to 856.97%; the TTM figure through Sep 2025 stood at 3927.51% (up 629149.0% YoY), while the FY2024 annual figure was 2340.29%, up 282412.0% from the prior year.
- Net Margin was 856.97% for Q4 2024 at Praxis Precision Medicines, up from 18819.54% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 856.97% in Q4 2024 to a low of 18819.54% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Praxis Precision Medicines | 200.22 Mn | -586.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -856.97% |
| Sep 30, 2024 | -18,819.54% |
| Jun 30, 2024 | -10,500.84% |
| Mar 31, 2024 | -9,718.33% |
| Dec 31, 2023 | -5,399.22% |
| Sep 30, 2023 | -5,452.14% |
| Jun 30, 2023 | -4,476.31% |
| Mar 31, 2023 | -5,577.01% |